Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Monday, September 14, 2015 6:42:02 PM
bullish
ascending triangle breakout
## source: finance.yahoo.com
Mon, 14 Sep 2015 12:53:12 GMT ~ Is Dermira (DERM) Stock a Solid Choice Right Now?
read full: http://finance.yahoo.com/news/dermira-derm-stock-solid-choice-125312034.html
*********************************************************
Thu, 10 Sep 2015 20:29:11 GMT ~ Krispy Kreme, Palo Alto, Con-Way are big movers
read full: http://finance.yahoo.com/news/krispy-kreme-palo-alto-con-202911657.html
*********************************************************
Thu, 10 Sep 2015 11:46:01 GMT ~ Skin Disposition Study Results for Dermira's DRM01 Program in Acne Presented at International Dermatology Meeting
[at noodls] - Animal Data Demonstrate Accumulation of DRM01 in Sebaceous Glands Following Topical Administration MENLO PARK, Calif., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical ...
read full: http://www.noodls.com/view/BDF00D3317CD8D9CF81A97A29CEB9FDF597DE610
*********************************************************
Thu, 10 Sep 2015 11:30:00 GMT ~ Skin Disposition Study Results for Dermira's DRM01 Program in Acne Presented at International Dermatology Meeting
[GlobeNewswire] - MENLO PARK, Calif. -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients, today announced ...
read full: http://finance.yahoo.com/news/skin-disposition-study-results-dermiras-113000301.html
*********************************************************
Thu, 03 Sep 2015 11:45:05 GMT ~ Dermira to Present Data for DRM01 Acne Program at 45th Annual ESDR Meeting
[at noodls] - Results of Skin Disposition Study to be Presented on September 10, 2015 MENLO PARK, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused ...
read full: http://www.noodls.com/view/5FD40BFB4F820381FA6F62CE984E441BEC0CA66B
*********************************************************
$DERM charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$DERM company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/DERM/company-info
Ticker: $DERM
OTC Market Place: Not Available
CIK code: not found
Company name: Dermira, Inc.
Incorporated In:
$DERM share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$DERM extra dd links
Company name: Dermira, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/DERM/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/DERM/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=DERM+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=DERM+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=DERM+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/DERM/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/DERM/news - http://finance.yahoo.com/q/h?s=DERM+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/DERM/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/DERM/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/DERM/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/DERM/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/DERM/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/DERM/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/DERM/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/DERM/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=DERM+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/DERM
DTCC (dtcc.com): http://search2.dtcc.com/?q=Dermira%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Dermira%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Dermira%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/DERM/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/DERM
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/DERM/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/DERM/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/DERM/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/DERM/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/DERM/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/DERM/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/DERM/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=DERM&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=DERM
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/DERM/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=DERM+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=DERM+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=DERM
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=DERM
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=DERM+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/DERM/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=DERM+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/DERM.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=DERM
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/DERM/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/DERM/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/DERM/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/DERM/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/DERM
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/DERM
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/DERM:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=DERM
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=DERM
$DERM DD Notes ~ http://www.ddnotesmaker.com/DERM
Recent DERM News
- Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/21/2024 08:01:27 PM
- Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea • GlobeNewswire Inc. • 03/18/2024 12:30:30 PM
- Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 • GlobeNewswire Inc. • 03/15/2024 12:30:01 PM
- Journey Medical Corporation to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/13/2024 12:30:14 PM
- Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting • GlobeNewswire Inc. • 03/11/2024 12:30:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:54:53 PM
- Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea • GlobeNewswire Inc. • 01/05/2024 01:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:05:34 PM
- Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million • GlobeNewswire Inc. • 01/02/2024 09:05:30 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/15/2023 09:46:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 10:01:17 PM
- Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea • GlobeNewswire Inc. • 12/06/2023 01:00:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:45:43 PM
- Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 11/07/2023 09:01:18 PM
- Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023 • GlobeNewswire Inc. • 10/31/2023 12:30:12 PM
- Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg) • GlobeNewswire Inc. • 10/20/2023 12:30:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 01:10:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 08:59:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 05:26:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:00:22 PM
- Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations • GlobeNewswire Inc. • 09/06/2023 12:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:00:17 PM
- Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 08/14/2023 08:01:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:45:50 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM